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DOES ABRASION PLEURODESIS INCREASE THE MORBIDITY OF VIDEO ASSISTED 
THORACIC SURGERY FOR PRIMARY PNEUMOTHORAX? 
Jinglong Li, Qigang Luo, Dazhi Pang, Alan D. Sihoe.  
The University of Hong Kong Shenzhen Hospital, Shenzhen, China.  
OBJECTIVE: Pneumothorax surgery is a frequently used model to investigate the impact of surgical 
approach on postoperative morbidity. However, the criticism that abrasion pleurodesis during such surgery 
may confound results by introducing additional morbidity has not been specifically investigated. 
 
METHODS: Prospectively collected data on consecutive patients receiving Video-Assisted Thoracic 
Surgery (VATS) for primary pneumothorax were retrospectively reviewed. Patients with secondary 
pneumothorax were excluded. All patients received similar surgery with bleb resection, with or without 
pleural abrasion performed according to surgeon preference. The size of the study cohort was calculated to 
demonstrate a difference in 1 point on a 10-point analog pain score (alpha 0.05; power 80%). 
 
RESULTS: The data for this cohort are summarized in the Table. There was no difference between the 
study arms in all major demographic and clinical characteristics. There was no mortality or major 
complication in all patients. Intraoperatively, pleural abrasion did not increase operation times or blood loss. 
Postoperatively, mean chest drain durations and lengths of stay were similar in the two study arms. 
Abrasion patients had a trend for higher total volume of fluid drained at the time of drain removal, but the 
absolute difference was clinically trivial (63ml). On a 10-point analog scale, pain scores on the 1
st
 and 2
nd
 
days after surgery were similar between the study arms, with a non-significant trend for lower mean score 
in the abrasion group on the 1
st
 postoperative day. All patients were given regular acetaminophen, and the 
requirement for additional analgesia (oral tramadol) for breakthrough pain was similar in the two study 
arms. After discharge, the study arms were similar in terms of time until completion resolution of pain, 
time until resumption of normal activity/work, and incidence of paresthesia. 
 
CONCLUSIONS: Abrasion pleurodesis does not add significant pain or morbidity to primary 
pneumothorax surgery. The pneumothorax surgery model can continue to be used to assess different 
surgical approaches. Further study is needed to determine the role of abrasion pleurodesis on pneumothorax 
recurrence. 
 
No Abrasion 
(n=22) 
With Abrasion 
(n=14) 
P value 
Baseline characteristics 
Sex 18 (81.8%) 11 (78.6%) 0.810 
Mean age (years) 26.9 ± 7.7 31.9 ± 8.7 0.092 
Smoking history 6 (27.3%) 5 (35.7%) 0.592 
Previous episodes of pneumothorax 11 (50.0%) 4 (28.6%) 0.204 
Duration of symptoms prior to admission (hours) 65.3 ± 101.6 121.1 ± 140.5 0.211 
Presentation with chest pain 22 (100.0%) 13 (92.9%) 0.204 
Presentation with dyspnea 2 (9.1%) 4 (28.6%) 0.126 
Presentation with cough 3 (13.6%) 1 (7.1%) 0.546 
Right side pneumothorax 13 (59.1%) 7 (50.0%) 0.593 
Estimated size of pneumothorax on presentation (%) 50.5 ± 24.3 57.1 ± 24.2 0.430 
Outcomes 
Mean operation time (mins) 75.9 ± 31.9 81.3 ± 32.4 0.641 
Mean blood loss (ml) 16.4 ± 7.7 18.6 ± 18.8 0.681 
Mean chest drain duration (hours) 40.1 ± 77.2 37.1 ± 26.6 0.872 
Mean total drainage at time of drain removal (ml) 76.3 ± 97.6 139.3 ± 110.1 0.097 
Mean length of stay (days) 3.7 ± 1.6 3.9 ± 1.9 0.687 
Mean pain score on postop day 1 (0-10) 3.0 ± 0.9 2.4 ± 0.8 0.068 
Mean pain score on postop day 2 (0-10) 2.5 ± 0.6 2.1 ± 0.9 0.172 
Mean use of ‘as required’ Tramadol on post-op day 1 (mg) 125.0 ± 99.7 146.4 ± 79.6 0.481 
Mean use of ‘as required’ Tramadol on post-op day 2 (mg) 104.5 ± 104.6 100.0 ± 76.0 0.881 
Mean duration until complete absence of pain (days) 45.5 ± 53.1 37.9 ± 30.8 0.586 
Mean duration until resumption of normal activity/work (days) 21.7 ± 12.7 26.4 ± 25.4 0.530 
Paresthesia after surgery 14 (63.6%) 5 (35.7%) 0.102 
 
